Paul M. Ridker – författare

Coronary heart disease remains the leading cause of death in both men and women in most industrialized countries. Yet it is largely preventable and health care providers can acquire the skills to help their patients reduce their risks substantially. This is a state-of-the-art compendium of the scientific evidence on the efficacy of coronary disease prevention. By translating the theory of prevention cardiology into feasible implementation, it will help clinicians develop intervention skills to utilize available knowledge. Counselling and other intervention strategies described in this textbook have documented clinical efficacy and cost-effectiveness, and they require little time to learn or implement.

Written and edited by world-renowned leaders in the field!Presents new directions for the prevention and treatment of arterial and venous cardiovascular thrombotic and thromboembolic diseases.Updates contemporary thinking regarding low-molecular-weight-heparins (LMWH), platelet receptor antagonists, and direct thrombin inhibitors to manage acute coronary syndromes.Evaluates contemporary strategies for anticoagulation and antiplatelet therapy to improve early clinical outcomes following percutaneous coronary intervention.Offering diagnostic and management strategies to reduce morbidity and mortality from acute coronary syndromes and acute pulmonary embolism, Thrombosis and Thromboembolism is a superb reference for cardiologists, internists, primary care physicians, vascular medicine specialists, vascular surgeons, hematologists, pulmonologists and critical care physicians, cardiovascular surgeons, cardiac care nurses, and upper-level undergraduate, graduate, and medical school students in these disciplines.

Written and edited by world-renowned leaders in the field!Presents new directions for the prevention and treatment of arterial and venous cardiovascular thrombotic and thromboembolic diseases.Updates contemporary thinking regarding low-molecular-weight-heparins (LMWH), platelet receptor antagonists, and direct thrombin inhibitors to manage acute coronary syndromes.Evaluates contemporary strategies for anticoagulation and antiplatelet therapy to improve early clinical outcomes following percutaneous coronary intervention.Offering diagnostic and management strategies to reduce morbidity and mortality from acute coronary syndromes and acute pulmonary embolism, Thrombosis and Thromboembolism is a superb reference for cardiologists, internists, primary care physicians, vascular medicine specialists, vascular surgeons, hematologists, pulmonologists and critical care physicians, cardiovascular surgeons, cardiac care nurses, and upper-level undergraduate, graduate, and medical school students in these disciplines.

Written and edited by world-renowned leaders in the field!Presents new directions for the prevention and treatment of arterial and venous cardiovascular thrombotic and thromboembolic diseases.Updates contemporary thinking regarding low-molecular-weight-heparins (LMWH), platelet receptor antagonists, and direct thrombin inhibitors to